Atlas Trials

Efficacy and Safety Study of CC-292 Versus Placebo as Co-therapy With Methotrexate in Active Rheumatoid Arthritis

Clinical trial NCT01975610 · COMPLETED

Trial details

NCT number
NCT01975610
Sponsor
Celgene
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Rheumatoid Arthritis
Start date
2013-10-01
Primary completion
2016-01-01
Enrollment
47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.